![Arthur Stril](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Arthur Stril
Direttore Finanziario/CFO presso
CELLECTIS S.A.
Patrimonio netto: 55 100 $ in data 30/06/2026
Profilo
Arthur Stril currently works at Primera Therapeutics, Inc., as Director from 2023, Cellectis SA, as Chief Financial & Business Officer from 2024, and Corps des Mines, as Member.
Mr. Stril received his undergraduate degree from École Normale Supérieure and graduate degree from the University of Cambridge.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
CELLECTIS S.A. 0,03% | 15/02/2026 | 18.651 ( 0,03% ) | 55 100 $ | 30/06/2026 |
Posizioni attive di Arthur Stril
| Società | Posizione | Inizio |
|---|---|---|
| CELLECTIS S.A. | Direttore Finanziario/CFO | 02/05/2024 |
Corps des Mines | Corporate Officer/Principal | - |
Formazione di Arthur Stril
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
53
Relazioni di 1° grado
4
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 4 |
|---|---|
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
École Normale Supérieure
 École Normale Supérieure Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Corps des Mines |
